8 reports

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • ISARNA THERAPEUTICS GMBH, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • ISARNA THERAPEUTICS GMBH, PHARMACEUTICALS & HEALTHCARE DEALS BY TYPE, 2012 TO YTD 2018

Summary Isarna Therapeutics GmbH (Isarna), formerly Antisense Pharma GmbH is a healthcare products provider that discovers and develops products for fibrotic diseases, ophthalmic, and cancers.The company offers antisense technology based drugs that treats aggressive tumor diseases. Its products include TGF-•...

  • Pharmaceutical
  • Germany
  • United States
  • Deals & Alliance
  • Isarna Therapeutics GmbH

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • ISARNA THERAPEUTICS GMBH
  • NOV 04, 2014: ONCODESIGN ANNOUNCES THE THIRD EXTENSION OF A RESEARCH CONTRACT WITH ISARNA THERAPEUTICS

FEB ##, 2013: ANTISENSE PHARMA PROVIDES UPDATE ON CLINICAL DEVELOPMENT PROGRAM OF TRABEDERSEN Antisense Pharma GmbH, a German pharmaceutical company, announced its revised corporate and development strategy, receiving full support from its main investors.

  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • Isarna Therapeutics GmbH
  • GENZYME CORP
  • NOV 04, 2014: ONCODESIGN ANNOUNCES THE THIRD EXTENSION OF A RESEARCH CONTRACT WITH ISARNA THERAPEUTICS

The molecules developed by companies in Phase III, Phase II, Phase I and Preclinical stages are ##, ##, ## and ## respectively.

  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • World
  • Isarna Therapeutics GmbH
  • PIPELINE BY ISARNA THERAPEUTICS GMBH, H1 2018

FEB ##, 2013: ANTISENSE PHARMA PROVIDES UPDATE ON CLINICAL DEVELOPMENT PROGRAM OF TRABEDERSEN Antisense Pharma GmbH, a German pharmaceutical company, announced its revised corporate and development strategy, receiving full support from its main investors.

  • Ophthalmology
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • Isarna Therapeutics GmbH